Oncimmune (ONC) Stock Chart & Stock Price History GBX 15.08 +0.28 (+1.89%) (As of 12/20/2024 06:06 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider Trades Oncimmune Stock Price Performance 5 Day Performance+1.89%1 Month Performance-5.16%3 Month Performance-13.33%6 Month Performance+38.35%Year-To-Date Performance-40.16%1 Year Performance-44.15% Receive ONC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin ONC Stock Chart for Sunday, December, 22, 2024 ONC Chart by TradingView Oncimmune Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 15.30GBX 15.08-1.44%GBX 15.08GBX 1542,510 shs£11.18 million12/19/2024GBX 14.90GBX 15.30+2.68%GBX 15.30GBX 1575,148 shs£11.34 million12/18/2024GBX 14.80GBX 14.90+0.68%GBX 15GBX 14.60129,773 shs£11.05 million12/17/2024GBX 15.85GBX 14.80-6.62%GBX 15.10GBX 14.60180,546 shs£10.97 million12/16/2024GBX 15.65GBX 15.85+1.28%GBX 15.85GBX 15.8522,058 shs£11.75 million12/13/2024GBX 15.65GBX 14.66-6.33%GBX 14.66GBX 14.6612,000 shs£10.87 million Get the Latest News and Ratings for ONC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncimmune and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 14.70GBX 15.65+6.46%GBX 15.65GBX 14.738,700 shs£11.60 million12/11/2024GBX 16.40GBX 14.70-10.37%GBX 14.73GBX 14.708,772 shs£10.90 million12/10/2024GBX 15.50GBX 16.40+5.81%GBX 16.40GBX 161.00 million shs£12.16 million12/09/2024GBX 15.50GBX 15.50GBX 16.01GBX 151.06 million shs£11.49 million12/06/2024GBX 15GBX 14.50-3.33%GBX 15.35GBX 14.50208,810 shs£10.75 million12/05/2024GBX 14.61GBX 15+2.65%GBX 15GBX 157,000 shs£11.12 million12/04/2024GBX 15.10GBX 14.61-3.23%GBX 14.61GBX 14.612,400 shs£10.83 million12/03/2024GBX 14.71GBX 15.10+2.64%GBX 15.10GBX 14.6034,100 shs£11.20 million12/02/2024GBX 14.75GBX 14.71-0.26%GBX 15.50GBX 14.71391,881 shs£10.91 million11/29/2024GBX 14.80GBX 14.90+0.68%GBX 14.98GBX 14.90273,552 shs£11.05 million11/28/2024GBX 15.05GBX 14.80-1.69%GBX 15.60GBX 14.6069,020 shs£10.97 million11/27/2024GBX 15.84GBX 15.05-4.96%GBX 15.16GBX 15.0527,583 shs£11.16 million11/26/2024GBX 14.60GBX 15.84+8.49%GBX 15.84GBX 15.1235,100 shs£11.74 million11/25/2024GBX 15.35GBX 14.60-4.89%GBX 15.14GBX 14.60126 shs£10.82 million11/22/2024GBX 15.15GBX 15.90+4.95%GBX 15.90GBX 15.1442,721 shs£11.79 million11/21/2024GBX 15.10GBX 15.15+0.33%GBX 15.24GBX 15.10101,185 shs£11.23 million Related Companies SBTX Stock Price Chart TRX Stock Price Chart POLB Stock Price Chart SAR Stock Price Chart AREC Stock Price Chart OPTI Stock Price Chart OBI Stock Price Chart NSCI Stock Price Chart SNG Stock Price Chart BVX Stock Price Chart Receive ONC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncimmune and its competitors with MarketBeat's FREE daily newsletter. This page (LON:ONC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
